Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
3h
Intellia Therapeutics: Promising Phase 2 Results and Attractive Valuation Spur Buy Recommendation
JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...
newsbytesapp.com
13h
CRISPR: News
Find Latest News, Videos and Pictures about CRISPR. Explore latest updates, news, information from NewsBytes. All about CRISPR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
DOJ reaches settlement
DA urges resentencing
Workers reject new contract
Accused of plagiarism
Oldest person in US dies
Grizzly bear fatally struck
Kristy now Category 4
Reporter struck by shrapnel
LA Times editor quits
CO elephants' rights case
Sued by ‘ring boys’
US charges media tycoon
Arbery case retrial motions
To join Harris at rally
Hikes annual pass prices
Pneumococcal vax advice
Seeks WI ballot exit
Israeli strike on school
911 calls from rally released
Unveils new AI rules
Georgia repels cyberattack
Carbon removal firms report
PA provisional ballot ruling
Wins EU antitrust case
New lead dust standards
Georgia citizenship audit
Data privacy violations fine
Philly synagogue targeted
Feedback